Lee David K 4
4 · iTeos Therapeutics, Inc. · Filed Dec 7, 2023
Insider Transaction Report
Form 4
Lee David K
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-12-05+44,766→ 44,766 totalExercise: $9.84Exp: 2033-12-05→ Common Stock (44,766 underlying)
Footnotes (1)
- [F1]This stock option shall vest over 3 years, with 1/3 vesting on December 5, 2024, and thereafter in equal monthly installments over the next 24 months, subject to the Reporting Person's continued service as a director through the applicable vesting date.